TLDR The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.
The document discusses two case studies of women with classical-like Ehlers-Danlos syndrome (clEDS) type 2, a rare genetic disorder caused by variants in the AEBP1 gene. Both patients exhibited symptoms like joint hypermobility, easy bruising, and hair loss. The study found that 6 out of 11 total reported cases of clEDS type 2 experienced hair loss resembling androgenetic alopecia, a type of hair loss not reported in other EDS types. The study suggests that WNT signalling, which maintains the hair follicle, could be disrupted in individuals with pathogenic AEBP1 variants, leading to this specific phenotype. However, there is currently no published data to support this theory. The study also recommends cardiovascular investigation and ongoing surveillance for individuals with clEDS type 2 due to the risk of cardiovascular events.
30 citations,
June 2021 in “British Journal of Dermatology” Mutations in the WNT10A gene can cause skin, hair, teeth, and other disorders, and may also affect other areas like kidney and cancer, with potential for targeted treatments.
20 citations,
February 2019 in “Genes” The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.
153 citations,
March 2017 in “Endocrine” Male pattern baldness involves genetics, hormones, and needs better treatments.
95 citations,
May 2012 in “British Journal of Dermatology” Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.
20 citations,
February 2019 in “Genes” The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.
1 citations,
November 2011 in “British journal of pharmacology” Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.
19 citations,
December 2016 in “PLOS ONE” Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.
March 2024 in “Frontiers in genetics” Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.
New insights into cell communication in psoriasis suggest innovative drug treatments.
